ANXA4 and metastatic malignant neoplasm in the lymph nodes: The strong ANXA4 expression rate in the lymph node metastasis group was 90.0%(9/10), which was higher than the group without lymph node metastasis(58.1%, 43/74), but not significant, (P<0.05, P=0.109).